risk of death – Page 22 – Communicable Diseases Research

Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level

Article

Published on 2021-03-212022-10-31
Journal: Cancers [Category] COVID-19,

COVID ‐19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case‐controlled study from Iran

Original Article

Published on 2021-03-202022-10-31
Journal: Cancer Reports [Category] COVID-19, MERS, SARS,

Cardiac Injury Biomarkers and the Risk of Death in Patients with COVID-19: A Systematic Review and Meta-Analysis

Review Article

Published on 2021-03-182022-10-31
Journal: Cardiology Research and Practice [Category] COVID-19,

[키워드] Admission analyzed Biomarker C-reactive protein cardiac cardiac complication cardiac injury cardiac troponin Care carried CK-MB close monitoring cohort study Concentration COVID-19 COVID-19 patient COVID-19 patients CRP cTn cTnT dead dead patient death death in COVID-19 defined develop elevated Hospitalization IL-6 Immune-mediated inclusion criteria increased risk Injury interleukin-6 males marker Meta-analysis Mortality myocardial injury Myoglobin N-terminal novel coronavirus disease objective Patient patients plasma cTnT pro-B-type natriuretic peptide Prognosis proportion Radiographic reduce Result review risk risk factor risk of death risk ratio RRs secondary severe complication significantly higher standardized mean difference subsequent Survivors systematic review upper reference limit
[DOI] 10.1155/2021/9363569 PMC 바로가기 [Article Type] Review Article

Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study

Article

Published on 2021-03-162022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] 95%CI absence affected age baseline characteristics Cancer cancer patient Chemotherapy cohort study complications confounding variable Corona COVID-19 COVID-19 pandemic Critical data set Desaturation dissemination Dyspnea Effect event Follow-up high risk independent Infection International interstitial pneumonia interval Italian Italy less lombardy management median median age Mortality multicenter Neutral occurred outcome pandemic Patient predictors Prognosis Prognostic factor Ratio receiving recommendations Region remained risk factor risk of death SACT SARS-CoV-2 SARS-COV-2 infection severe COVID-19 simple study population Systemic anti-cancer treatment therapy Treatment vaccination vulnerable patient while
[DOI] 10.3390/cancers13061324 PMC 바로가기 [Article Type] Article

Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients

Research Articles

Published on 2021-03-152022-10-30
Journal: Intensive Care Medicine Experimental [Category] COVID-19,

[키워드] addition administration affecting Analysis Biomarker Blood blood cell count Cell Characteristics circulating Clinical data Cohort collected Comorbidities contribute COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity Critical critical COVID-19 patient critical COVID-19 patients Critically ill Critically ill patient declining differentially expressed gene erythrocyte fatality fluctuation greater hallmark hemoglobin independent indicated longitudinal melatonin metabolism molecular Multi-omics network analysis Non-survivors outcome outcomes pathway performed poor prognosis potential mechanism Prognosis Prognostic marker Result risk of death selected serum sample significantly significantly increased suppressed survival survivor thought transcriptional whole blood sample
[DOI] 10.1186/s40635-021-00373-z PMC 바로가기 [Article Type] Research Articles

Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths

Research Paper

Published on 2021-03-152022-10-28
Journal: Aging (Albany NY) [Category] COVID-19, SARS,

[키워드] age and gender Analysis B cell C-reactive protein CD4 CD8 Characteristics clinical Clinical characteristics collected COVID-19 COVID-19 patient COX D-dimer death death in COVID-19 demonstrated develop died early stage electronic medical records evaluate groups high risk hospitalized COVID-19 patient identify immunological characteristics increased the risk laboratory data Lymphocyte count Lymphocytes Mortality multiple logistic regression natural killer cell neutrophil neutrophil count NK cells Patient reduce researcher risk factor risk of death SARS-CoV-2 SARS-COV-2 infection severe disease significant decrease significantly higher significantly lower subset T cell T cells Total White blood cell Wuhan, China
[DOI] 10.18632/aging.202819 PMC 바로가기 [Article Type] Research Paper

Outcomes of COVID-19 patients with comorbidities in southwest Nigeria

Research Article

Published on 2021-03-152022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

Different Appearance of Chest CT Images of T2DM and NDM Patients with COVID-19 Pneumonia Based on an Artificial Intelligent Quantitative Method

Research Article

Published on 2021-03-112022-10-30
Journal: International Journal of Endocrinology [Category] COVID-19,

Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)

COVID-19 치료를 위한 중재: 메타 분석 및 시험 순차 분석이 포함된 살아있는 체계적인 검토의 두 번째 판(The LIVING 프로젝트)

Meta-Analysis

Published on 2021-03-112022-08-13
Journal: PLoS ONE [Category] Biochemistry, SARS, 임상, 진단, 치료제,

[키워드] 95% CI 95% confidence interval adjusted Admission aggregate data meta-analyses all age group all age groups all-cause mortality Analysis boundary bromhexine caused certainty certainty of evidence Clinical research Clinical significance Cochrane guidelines comparison Comparisons Corticosteroid Corticosteroids COVID-19 database Effect Effects eight events Evidence evidence of Families FIVE Fixed-effect meta-analysis futility GRADE high risk Hydroxychloroquine Immunoglobulin indicate indication indications individual patient data meta-analyses individuals information intensive care Intervention effects intravenous Intravenous immunoglobulin lack life Lopinavir Lopinavir-ritonavir mechanical ventilation meta-analyses Meta-analysis moderate Network meta-analysis no evidence of non-serious adverse non-serious adverse events on mechanical ventilation outcome outcomes participant Participants patient data performed Primary outcomes PRISMA Quality of life random error random errors random-effects meta-analyses randomized clinical trial randomized clinical trials rapidly spreading disease reached reduce reduced Remdesivir renal replacement therapy replacement therapy required Research risk risk of death risk ratio risks of bia Ritonavir searched second secondary Secondary outcomes sequential analysis Serious Adverse Event Serious Adverse Events single trial standard care statistically significant systematic review threshold Tocilizumab Treatment treatment for COVID-19 treatment intervention treatments of COVID-19 Trial Trial methodology trial sequential analyses trial sequential analysis website with COVID-19
[DOI] 10.1371/journal.pone.0248132 PMC 바로가기 [Article Type] Meta-Analysis

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

002

Published on 2021-03-102022-10-31
Journal: HemaSphere [Category] COVID-19,

[키워드] 95% confidence interval acute respiratory syndrome age blood pressure Cancer Chronic kidney disease concerning Confusion coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19 in patient demonstrated disease Factor Follow-up General population hazard ratio heterogeneous increased mortality lymphoma male median median age modify Mortality mortality risk multicenter multicenter study no difference outcomes overall mortality Patient patients with COVID-19 persistence polymerase chain regimens respiratory rate Retrospective study risk factor risk of death significantly significantly increased Spain therapeutic Treatment urea concentration
[DOI] 10.1097/HS9.0000000000000538 PMC 바로가기 [Article Type] 002